Due to this, drugs that activate BK channels could represent a novel therapeutic strategy for treatment of certain types of epilepsy, bladder instability, erectile dysfunction, ischemic heart disease and chronic obstructive pulmonary disease. This evidence concerns the gene KCNMA1 and erectile dysfunction.